SCCA-IC serum levels are predictive of clinical response in HCV chronic hepatitis to antiviral therapy: a multicentric prospective study.
about
Clinical applications of squamous cell carcinoma antigen-immunoglobulins M to monitor chronic hepatitis CSpecificity of squamous cell carcinoma antigen (SCCA)-IgM detection in patients with HCV infection and rheumatoid factor seropositivity.HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patients.Circulating SCCA-IgM complex is a useful biomarker to predict the outcome of therapy in hepatocellular carcinoma patients.
P2860
SCCA-IC serum levels are predictive of clinical response in HCV chronic hepatitis to antiviral therapy: a multicentric prospective study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
SCCA-IC serum levels are predi ...... ulticentric prospective study.
@en
SCCA-IC serum levels are predi ...... ulticentric prospective study.
@nl
type
label
SCCA-IC serum levels are predi ...... ulticentric prospective study.
@en
SCCA-IC serum levels are predi ...... ulticentric prospective study.
@nl
prefLabel
SCCA-IC serum levels are predi ...... ulticentric prospective study.
@en
SCCA-IC serum levels are predi ...... ulticentric prospective study.
@nl
P2093
P2860
P50
P1476
SCCA-IC serum levels are predi ...... multicentric prospective study
@en
P2093
E Fransvea
M Quaranta
S Antonaci
V Bernabucci
P2860
P304
P356
10.1111/J.1365-2893.2012.01604.X
P577
2012-03-30T00:00:00Z